Local Covid vaccines undergo human trials

Local Covid vaccines undergo human trials

Four out of more than 20 Covid-19 vaccine candidates being developed in Thailand are now being tested on humans, the final process required before they are submitted for approval by the Food and Drug Administration (FDA), the government said on Saturday.

Rachada: Swift progress made

The vaccines are Chula-Cov19, HXP-GPOVac, Baiya Sars-CoV-2 Vax and Covigen, said deputy government spokeswoman Rachada Dhnadirek.

Ms Rachada said other vaccine candidates found to have promising results in lab-controlled trials were the viral vector, protein subunit, mRNA and virus-like particle (VLP) types.

This swift vaccine development is a result of cooperation among multiple parties including the National Vaccine Institute (NVI), Government Pharmaceutical Organisation (GPO), National Center for Genetic Engineering and Biotechnology (Biotec), Chulalongkorn University and Mahidol University, she said.

As for the Covid-19 vaccine nasal spray that has become increasingly popular, she said Biotec is developing one called "Nastvac" which has already passed tests on animals.

"About 200 to 300 doses of this vaccine candidate are expected to be produced ahead of the next set of clinical trials in the second quarter of this year," she said.

"A Covid-19 antibody nasal spray is also being developed by five partners, namely Chulalongkorn University, Silpakorn University, Health Systems Research Institute, the GPO and HIBIOCY Co."

The cabinet late last year approved a budget of 2.3 billion baht to help develop the homegrown messenger RNA (mRNA)-based ChulaCov19 vaccine against Covid-19.

It has also approved 1.3 billion baht to fund the development of Baiya Sars-CoV-2 Vax, a plant-based vaccine being developed by Baiya Phytopharm, a startup company under the CU Enterprise programme.

Do you like the content of this article?

Beautiful freedom

The former Myanmar beauty queen who slammed the country's junta and was detained at Suvarnabhumi last week is free to fly to Canada, where she has been granted refugee status.


Royal inspiration for a sustainable future

Thais who have learned His Majesty King Bhumibol Adulyadej the Great’s Sufficiency Economy Philosophy (SEP) are ready to put it into action as the whole world increasingly moves toward sustainable development, said Sumet Tantivejkul, Secretary-General of the Chaipattana Foundation.


Ant Group's Alipay+ to boost cashless travel in South Korea

HONG KONG: Chinese financial technology giant Ant Group is ramping up cashless travel in South Korea through its Alipay+ programme, which supports a major collaboration between trusted mobile payment services providers across Asia.